Abstract |
Owing to its flexibility and high treatment efficiency, phototherapy is rapidly emerging for treating bacteria-induced diseases, but how to improve the sensitivity of bacteria to reactive oxygen species (ROS) and heat simultaneously to kill bacteria under mild conditions is still a challenge. Herein, we designed a NIR light catalyst (Bi2S3-S-nitrosothiol-acetylcholine (BSNA)) by transforming •O2- into peroxynitrite in situ, which can enhance the bacterial sensibility to ROS and heat and kill bacteria under a mild temperature. The transformed peroxynitrite in situ possessed a stronger ability to penetrate cell membranes and antioxidant capacity. The BSNA nanoparticles (NPs) inhibited the bacterial glucose metabolic process through down-regulated xerC/xerD expression and disrupted the HSP70/HSP90 secondary structure through nitrifying TYR179. Additionally, the synergistic effect of the designed BSNA and clinical antibiotics increased the antibacterial activity. In the case of tetracycline-class antibiotics, BSNA NPs induced phenolic hydroxyl group structure changes and inhibited the interaction between tetracycline and targeted t- RNA recombinant protein. Besides, BSNA stimulated production of more CD8+ T cells and reduced common complications in peritonitis, which provided immunotherapy activity. The targeted and anti-infective effect of BSNA suggested that we propose a nanotherapeutic strategy to achieve more efficient synergistic therapy under mild temperatures.
|
Authors | Yuan Li, Xiangmei Liu, Zhenduo Cui, Yufeng Zheng, Hui Jiang, Yu Zhang, Yanqin Liang, Zhaoyang Li, Shengli Zhu, Shuilin Wu |
Journal | ACS nano
(ACS Nano)
Vol. 16
Issue 9
Pg. 14860-14873
(09 27 2022)
ISSN: 1936-086X [Electronic] United States |
PMID | 36094899
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Anti-Bacterial Agents
- Antioxidants
- Reactive Oxygen Species
- Recombinant Proteins
- S-Nitrosothiols
- Sulfides
- Tetracyclines
- Peroxynitrous Acid
- RNA
- Glucose
- Acetylcholine
- Bismuth
- bismuth sulfide
|
Topics |
- Acetylcholine
- Anti-Bacterial Agents
(chemistry, pharmacology, therapeutic use)
- Antioxidants
- Bacteria
(metabolism)
- Bacterial Infections
(drug therapy)
- Bismuth
- CD8-Positive T-Lymphocytes
- Glucose
- Humans
- Immunotherapy
- Nanoparticles
(chemistry)
- Peroxynitrous Acid
- Phototherapy
- RNA
- Reactive Oxygen Species
(metabolism)
- Recombinant Proteins
- S-Nitrosothiols
- Sulfides
(chemistry, pharmacology, therapeutic use)
- Tetracyclines
|